نتایج جستجو برای: naloxone

تعداد نتایج: 4623  

Journal: :American journal of public health 2009
Maya Doe-Simkins Alexander Y Walley Andy Epstein Peter Moyer

Administering naloxone hydrochloride (naloxone) during an opioid overdose reverses the overdose and can prevent death. Although typically delivered via intramuscular or intravenous injection, naloxone may be delivered via intranasal spray device. In August 2006, the Boston Public Health Commission passed a public health regulation that authorized an opioid overdose prevention program that inclu...

Journal: :Addiction 2009
Debra Kerr Anne-Maree Kelly Paul Dietze Damien Jolley Bill Barger

AIMS Traditionally, the opiate antagonist naloxone has been administered parenterally; however, intranasal (i.n.) administration has the potential to reduce the risk of needlestick injury. This is important when working with populations known to have a high prevalence of blood-borne viruses. Preliminary research suggests that i.n. administration might be effective, but suboptimal naloxone solut...

Journal: :The American journal on addictions 2004
Leslie Amass Walter Ling Thomas E Freese Chris Reiber Jeffrey J Annon Allan J Cohen Dennis McCarty Malcolm S Reid Lawrence S Brown Cynthia Clark Douglas M Ziedonis Jonathan Krejci Susan Stine Theresa Winhusen Greg Brigham Dean Babcock Joan A Muir Betty J Buchan Terry Horton

In October 2002, the U.S. Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for Clinical Trials Network (CTN) sponsored two clinical trials assessing buprenorphine-naloxone for short-term opioid detoxification. These trials provid...

Journal: :Anesthesiology 1989
Eveline van Dorp Ashraf Yassen Elise Sarton Raymonda Romberg Erik Olofsen Luc Teppema Meindert Danhof Albert Dahan

BACKGROUND The objective of this investigation was to examine the ability of the opioid antagonist naloxone to reverse respiratory depression produced by the mu-opioid analgesic, buprenorphine, in healthy volunteers. The studies were designed in light of the claims that buprenorphine is relatively resistant to the effects of naloxone. METHODS In a first attempt, the effect of an intravenous b...

Journal: :Molecular cancer therapeutics 2006
Mariya Farooqui Zhen H Geng Elliot J Stephenson Nurulain Zaveri Douglas Yee Kalpna Gupta

Estrogen promotes the growth of breast cancer via estrogen receptors (ER). Earlier studies showed that the opioid receptor antagonist naloxone inhibits MCF-7 breast cancer growth in mice. We examined the cellular and molecular mechanism of naloxone antagonism of ERalpha activity in human MCF-7 cells. Naloxone (100 nmol/L) inhibited 17beta-estradiol (E2)-induced (10 nmol/L) MCF-7 cell proliferat...

Journal: :The journal of pain : official journal of the American Pain Society 2012
Susannah S Lewis Lisa C Loram Mark R Hutchinson Chien-Ming Li Yingning Zhang Steven F Maier Yong Huang Kenner C Rice Linda R Watkins

UNLABELLED Previous work demonstrated that both the opioid antagonist (-)-naloxone and the non-opioid (+)-naloxone inhibit toll-like receptor 4 (TLR4) signaling and reverse neuropathic pain expressed shortly after chronic constriction injury. The present studies reveal that the TLR4 contributes to neuropathic pain in another major model (spinal nerve ligation) and to long established (2-4 month...

Journal: :Scientia Pharmaceutica 2022

There is a need to develop dosage forms suitable for children improve drug treatment. Extemporaneous compounding of drugs one way meet these needs. However, excipients generally considered as safe in adults may not be appropriate intended children. The aim was optimize the composition two pediatric liquid preparations by substituting paraben microbiological preservative and ethanol solubilizer,...

Journal: :Harm Reduction Journal 2006
Nancy Worthington Tinka Markham Piper Sandro Galea David Rosenthal

BACKGROUND Drug-induced and drug-related deaths have been increasing for the past decade throughout the US. In NYC, drug overdose accounts for nearly 900 deaths per year, a figure that exceeds the number of deaths each year from homicide. Naloxone, a highly effective opiate antagonist, has for decades been used by doctors and paramedics during emergency resuscitation after an opiate overdose. F...

Journal: :Substance use & misuse 2008
Tinka Markham Piper Sharon Stancliff Sasha Rudenstine Susan Sherman Vijay Nandi Allan Clear Sandro Galea

Naloxone, an opiate antagonist that can avert opiate overdose mortality, has only recently been prescribed to drug users in a few jurisdictions (Chicago, Baltimore, New Mexico, New York City, and San Francisco) in the United States. This report summarizes the first systematic evaluation of large-scale naloxone distribution among injection drug users (IDUs) in the United States. In 2005, we cond...

Journal: :Journal of animal science 1986
C S Whisnant F N Thompson T E Kiser C R Barb

Two experiments were conducted with the opioid antagonist naloxone to determine the effect of opioid receptor blockade on hormone secretion in postpartum beef cows. In Exp. 1, nine anestrous postpartum beef cows were used to measure the effect of naloxone on serum luteinizing hormone (LH), cortisol and prolactin concentrations. Cows received either saline (n = 4) or 200 mg naloxone in saline (n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید